A systematic review (Boonpattharatthiti et al., 2024) indicated that the overall prevalence of adherence to insulin therapy is remarkably low, with adherence for T1D being 52.63% for T2D being 52.55%. The gene discussed is INS; the disease is type 1 diabetes mellitus.